Assessment of Effectiveness of Belatacept Patient Alert Card in Patients Following Renal Transplantation in a Sample of EU Countries

CompletedOBSERVATIONAL
Enrollment

63

Participants

Timeline

Start Date

November 29, 2016

Primary Completion Date

May 19, 2017

Study Completion Date

May 19, 2017

Conditions
Renal Transplant
Trial Locations (14)

1307

Local Institution, Dresden

24105

Local Institution, Kiel

25030

Local Institution, Besançon

29200

CHU Brest Hopital La Cavale Blanche, Brest

31059

CHU Toulouse Hopital Rangueli, Toulouse

33000

CHU Bordeaux Hopital Pellegrin, Burdeux

37000

CHU Tours Hopital Bretonneau, Tours

63000

CHU Clemont Ferrand, Clermont-Ferrand

68167

UK Mannheim, Mannheim

75185

Local Institution, Uppsala

94000

APHP Hopital Henri Mondor, Créteil

94270

Local Institution, Le Kremlin-Bicêtre

A-4020

Local Institution, Linz

A-1090

Local Institution, Vienna

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY